Skip to Content

Triamcinolone Acetonide Intravitreal Injection

Last Updated: April 27, 2020
Status: Current

Products Affected - Description
    • Triesence intravitreal suspension for injection, Novartis, 40 mg/mL, 1 mL vial, NDC 00065-0543-01
Reason for the Shortage
    • Novartis has Triesence on shortage due to manufacturing delays.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Novartis has Triesence 40 mg/mL 1 mL vials on limited allocation.

Updated

Updated April 27, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 27, 2019 by Rachael Freeman, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide